> top > docs > PubMed:11342977 > annotations

PubMed:11342977 JSONTXT

Annnotations TAB JSON ListView MergeView

DisGeNET

Id Subject Object Predicate Lexical cue
T0 344-347 gene:5130 denotes CTA
T1 379-395 disease:C0205851 denotes germ cell tumors
T2 344-347 gene:5130 denotes CTA
T3 490-506 disease:C0205851 denotes germ cell tumors
T4 344-347 gene:5130 denotes CTA
T5 540-553 disease:C0596263 denotes tumorigenesis
T6 472-475 gene:5130 denotes CTA
T7 379-395 disease:C0205851 denotes germ cell tumors
T8 472-475 gene:5130 denotes CTA
T9 490-506 disease:C0205851 denotes germ cell tumors
T10 472-475 gene:5130 denotes CTA
T11 540-553 disease:C0596263 denotes tumorigenesis
R1 T0 T1 associated_with CTA,germ cell tumors
R2 T2 T3 associated_with CTA,germ cell tumors
R3 T4 T5 associated_with CTA,tumorigenesis
R4 T6 T7 associated_with CTA,germ cell tumors
R5 T8 T9 associated_with CTA,germ cell tumors
R6 T10 T11 associated_with CTA,tumorigenesis

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
11342977-2#23#26#gene5130 344-347 gene5130 denotes CTA
11342977-2#219#232#diseaseC0596263 540-553 diseaseC0596263 denotes tumorigenesis
11342977-5#47#50#gene5130 1067-1070 gene5130 denotes CTA
11342977-5#120#136#diseaseC0205851 1140-1156 diseaseC0205851 denotes germ cell tumors
23#26#gene5130219#232#diseaseC0596263 11342977-2#23#26#gene5130 11342977-2#219#232#diseaseC0596263 associated_with CTA,tumorigenesis
47#50#gene5130120#136#diseaseC0205851 11342977-5#47#50#gene5130 11342977-5#120#136#diseaseC0205851 associated_with CTA,germ cell tumors

PubMed_Structured_Abstracts

Id Subject Object Predicate Lexical cue
T1 118-632 OBJECTIVE denotes The human cancer-testis antigens (CTAs) are a group of tumor specific antigens recognized by cytotoxic T lymphocytes whose expression occurs in human malignancies as well as in normal testicular tissue. We studied a series of CTA gene transcripts in testicular germ cell tumors of various histological types to test the hypothesis that the expression of CTA in testicular germ cell tumors reflects developmental stages of tumorigenesis rather than constitutive tumor antigens recognized by cytotoxic T lymphocytes.
T2 656-1010 METHODS denotes Total RNA was obtained from 31 primary and 3 metastatic testicular germ cell tumors, and 11 parenchymal tissues adjacent to the testicular germ cell tumors. We performed an expression study of the CTA genes MAGE-A, MAGE-B, GAGE, PAGE-1, HOM-MEL-40 (SSX2), NY-ESO-1, LAGE-1 and SCP-1 in these samples using reverse transcriptase-polymerase chain reaction.
T3 1020-1695 RESULTS denotes The results showed that expression patterns of CTA genes depended on the histological differentiation of the testicular germ cell tumors. Overall CTA expression was more common in seminomas than in nonseminomatous germ cell tumors. Specifically all 13 seminomas (100%) demonstrated the positive expression of MAGE-B1 and MAGE-B2, while 3 of 17 nonseminomatous germ cell tumor samples (18%) showed positive expression of these genes. All 5 teratomatous elements (100%) had homogenous null expression with regard to all CTA genes examined. In addition, we detected deficiencies in CTA expression in 7 of 11 parenchymal tissues adjacent to the testicular germ cell tumors (64%).
T4 1709-1935 CONCLUSIONS denotes These data support the idea that CTA transcripts in testicular germ cell tumors serve as developmental footprints of testicular germ cell tumors rather than as constitutive tumor antigens recognized by cytotoxic T lymphocytes.